Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (491-500 of 759) with videos related to

Pageof 76
Sort By:
Blood Advances|December 24, 2025
Comprehensive Analysis of Subtype-Specific Outcomes and Management in Castleman Disease: A 20-Year Cohort StudyYoshito Nishimura, Thomas M Habermann, Morie A Gertz, et al.
American Journal of Hematology|October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluationYi L Hwa, Qian Shi, Shaji K Kumar, et al.
Mayo Clinic Proceedings|December 7, 2007
Prevalence of monoclonal gammopathy of undetermined significance among men in GhanaOla Landgren, Jerry A Katzmann, Ann W Hsing, et al.
Blood|June 9, 2025
Eliminating the need for sequential confirmation of response in multiple myelomaJean-Sébastien Claveau, Prashant Kapoor, Moritz Binder, et al.
European Journal of Haematology|February 8, 2014
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplantRahma Warsame, Soo Mee Bang, Shaji K Kumar, et al.
Kidney International|August 27, 2019
The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometryMaria L Gonzalez Suarez, Pingchuan Zhang, Samih H Nasr, et al.
Blood|January 12, 2012
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogeneticsShaji Kumar, Rafael Fonseca, Rhett P Ketterling, et al.
American Journal of Hematology|June 30, 2019
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosisSurbhi Sidana, M Hasib Sidiqi, Angela Dispenzieri, et al.
Blood|April 14, 2012
Clonal competition with alternating dominance in multiple myelomaJonathan J Keats, Marta Chesi, Jan B Egan, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Pageof 76

Showing results (491-500 of 759) with videos related to

Sort By:
Pageof 76
Blood Advances|December 24, 2025
Comprehensive Analysis of Subtype-Specific Outcomes and Management in Castleman Disease: A 20-Year Cohort StudyYoshito Nishimura, Thomas M Habermann, Morie A Gertz, et al.
American Journal of Hematology|October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluationYi L Hwa, Qian Shi, Shaji K Kumar, et al.
Mayo Clinic Proceedings|December 7, 2007
Prevalence of monoclonal gammopathy of undetermined significance among men in GhanaOla Landgren, Jerry A Katzmann, Ann W Hsing, et al.
Blood|June 9, 2025
Eliminating the need for sequential confirmation of response in multiple myelomaJean-Sébastien Claveau, Prashant Kapoor, Moritz Binder, et al.
European Journal of Haematology|February 8, 2014
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplantRahma Warsame, Soo Mee Bang, Shaji K Kumar, et al.
Kidney International|August 27, 2019
The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometryMaria L Gonzalez Suarez, Pingchuan Zhang, Samih H Nasr, et al.
Blood|January 12, 2012
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogeneticsShaji Kumar, Rafael Fonseca, Rhett P Ketterling, et al.
American Journal of Hematology|June 30, 2019
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosisSurbhi Sidana, M Hasib Sidiqi, Angela Dispenzieri, et al.
Blood|April 14, 2012
Clonal competition with alternating dominance in multiple myelomaJonathan J Keats, Marta Chesi, Jan B Egan, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Pageof 76